💡 : Use the SEC EDGAR Database to review the latest prospectus and full risk disclosures for these ETFs before investing. If you'd like to narrow this down, tell me:
Best for: Speculative bets on high-frontier tech like gene editing and CRISPR .
Strategy: Market-cap weighted, dominated by giants like Vertex, Gilead, and Amgen . Expense Ratio: 0.44% . Best for: Low-cost core exposure .
💡 : Use the SEC EDGAR Database to review the latest prospectus and full risk disclosures for these ETFs before investing. If you'd like to narrow this down, tell me:
Best for: Speculative bets on high-frontier tech like gene editing and CRISPR . best biotech etf to buy now
Strategy: Market-cap weighted, dominated by giants like Vertex, Gilead, and Amgen . Expense Ratio: 0.44% . Best for: Low-cost core exposure . 💡 : Use the SEC EDGAR Database to